TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide
Clinical trial NCT04610736 · COMPLETED
Trial details
- NCT number
- NCT04610736
- Sponsor
- Orphelia Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2023-01-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.